EA200600563A1 - Способ получения рензаприда и его промежуточных соединений - Google Patents

Способ получения рензаприда и его промежуточных соединений

Info

Publication number
EA200600563A1
EA200600563A1 EA200600563A EA200600563A EA200600563A1 EA 200600563 A1 EA200600563 A1 EA 200600563A1 EA 200600563 A EA200600563 A EA 200600563A EA 200600563 A EA200600563 A EA 200600563A EA 200600563 A1 EA200600563 A1 EA 200600563A1
Authority
EA
Eurasian Patent Office
Prior art keywords
renzaprid
obtaining
intermediate compounds
azabicyclo
endo
Prior art date
Application number
EA200600563A
Other languages
English (en)
Inventor
Ричард Михаэль Джон Палмер
Николас Лесли Мейерс
Джон Найт
Original Assignee
Ализайм Терапевтикс Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ализайм Терапевтикс Лимитед filed Critical Ализайм Терапевтикс Лимитед
Publication of EA200600563A1 publication Critical patent/EA200600563A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)

Abstract

Настоящее изобретение относится к усовершенствованному способу получения [(±)-эндо]-4-амино-5-хлоро-2-метокси-N-(1-азабицикло[3.3.1]-нон-4-ил)бензамида гидрохлорида и его промежуточных соединений.
EA200600563A 2003-09-09 2004-09-06 Способ получения рензаприда и его промежуточных соединений EA200600563A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0321091.1A GB0321091D0 (en) 2003-09-09 2003-09-09 Synthesis
PCT/GB2004/003820 WO2005023808A2 (en) 2003-09-09 2004-09-06 Process for the preparation of renzapride and intermediates thereof

Publications (1)

Publication Number Publication Date
EA200600563A1 true EA200600563A1 (ru) 2006-12-29

Family

ID=29226752

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600563A EA200600563A1 (ru) 2003-09-09 2004-09-06 Способ получения рензаприда и его промежуточных соединений

Country Status (17)

Country Link
US (2) US7189852B2 (ru)
EP (1) EP1664048A2 (ru)
JP (1) JP2007505089A (ru)
KR (1) KR20060092211A (ru)
CN (1) CN1849320A (ru)
AR (1) AR045625A1 (ru)
AU (1) AU2004270465A1 (ru)
BR (1) BRPI0414200A (ru)
CA (1) CA2537536A1 (ru)
EA (1) EA200600563A1 (ru)
GB (1) GB0321091D0 (ru)
IL (1) IL173736A0 (ru)
MX (1) MXPA06002743A (ru)
NO (1) NO20061575L (ru)
TW (1) TW200526661A (ru)
WO (1) WO2005023808A2 (ru)
ZA (1) ZA200601991B (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7811707B2 (en) * 2004-12-28 2010-10-12 Boston-Power, Inc. Lithium-ion secondary battery
US20080008933A1 (en) * 2005-12-23 2008-01-10 Boston-Power, Inc. Lithium-ion secondary battery
TWI426678B (zh) * 2006-06-28 2014-02-11 Boston Power Inc 具有多重充電率之電子裝置、電池組、充電於電子裝置中的鋰離子電荷儲存電源供應器之方法及可攜式電腦
US20090297937A1 (en) * 2008-04-24 2009-12-03 Lampe-Onnerud Christina M Lithium-ion secondary battery
WO2010030875A1 (en) * 2008-09-12 2010-03-18 Boston-Power, Inc. Method and apparatus for embedded battery cells and thermal management
US20100289457A1 (en) * 2009-05-18 2010-11-18 Boston-Power, Inc. Energy efficient and fast charge modes of a rechargeable battery
CN102481858B (zh) * 2009-09-01 2014-11-05 波士顿电力公司 大型电动载具的电池系统的安全和效能优化控制
JP2013504145A (ja) * 2009-09-01 2013-02-04 ボストン−パワー，インコーポレイテッド 大規模蓄電池システムおよび組み立て方法
JP7305615B2 (ja) 2017-07-21 2023-07-10 ローム アンド ハース カンパニー ポリ（メチルメタクリレート）樹脂組成物
MX2022002470A (es) * 2019-08-29 2022-03-22 Janssen Biotech Inc Inhibidores de dihidroorotato deshidrogenasa sustituidos con urea.
CN112094239A (zh) * 2020-11-03 2020-12-18 燃点(南京)生物医药科技有限公司 一种乌拉地尔杂质化合物、制备方法及其应用
CN113773219A (zh) * 2021-09-30 2021-12-10 内蒙古康普药业有限公司 一种甲氧氯普胺双氯新杂质的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2119724B2 (de) 1970-04-24 1976-04-29 Teikoku Hormone Manufacturing Co. Ltd., Tokio Verfahren zur herstellung einer halogensubstituierten benzoesaeure
JPS5010573B1 (ru) * 1970-04-24 1975-04-22
US4612319A (en) * 1982-04-14 1986-09-16 Beecham Group P.L.C. Bridged quinolizidinylbenzamides, compositions containing them and methods for their use
CA1223873A (en) * 1982-04-14 1987-07-07 Francis D. King Pharmaceutically active compounds
GB8523211D0 (en) 1985-09-19 1985-10-23 Beecham Group Plc Compounds
GB8607163D0 (en) * 1986-03-22 1986-04-30 Beecham Group Plc Chemical compound
US5330982A (en) * 1986-12-17 1994-07-19 Glaxo Group Limited Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
US5140023A (en) 1990-04-27 1992-08-18 G. D. Searle & Co. Azatetracycle compounds
KR970701705A (ko) 1994-03-11 1997-04-12 오노다 마사요시 5-HT₃ 수용체 효능제, 신규한 티아졸 유도체 및 이의 중간체(5-HT₃receptor agonist, novel thiazole derivative, and intermediate therefor)
GB0329319D0 (en) * 2003-12-18 2004-01-21 Alizyme Therapeutics Ltd Synthesis

Also Published As

Publication number Publication date
WO2005023808A3 (en) 2005-07-07
CA2537536A1 (en) 2005-03-17
US7189852B2 (en) 2007-03-13
WO2005023808A2 (en) 2005-03-17
BRPI0414200A (pt) 2006-10-31
IL173736A0 (en) 2006-07-05
US20050049416A1 (en) 2005-03-03
TW200526661A (en) 2005-08-16
EP1664048A2 (en) 2006-06-07
CN1849320A (zh) 2006-10-18
KR20060092211A (ko) 2006-08-22
ZA200601991B (en) 2009-08-26
NO20061575L (no) 2006-06-09
US20070135641A1 (en) 2007-06-14
MXPA06002743A (es) 2006-06-05
AU2004270465A1 (en) 2005-03-17
JP2007505089A (ja) 2007-03-08
GB0321091D0 (en) 2003-10-08
AR045625A1 (es) 2005-11-02

Similar Documents

Publication Publication Date Title
NO20061575L (no) Fremgangsmate for fremstilling av renzapride og mellomprodukter derav
TW200716583A (en) Crystal forms of {[(2R)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
EA200100971A1 (ru) Новые соединения и композиции в качестве ингибиторов протеазы
SE0301373D0 (sv) Novel compounds
EA201200669A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
HUP0302345A2 (hu) Új triazolo-pirimidin-vegyületek, ezek intermedierjei és eljárás az előállításukra
EA200800760A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
EA200401157A1 (ru) N-аминоацетилпирролидин-2-карбонитрилы и их применение в качестве ингибиторов ddp-iv
EA200400953A1 (ru) Замещённые пиридиноны в качестве модуляторов map-киназы p38
MA29135B1 (fr) Potentialisateurs de recepteurs du glutamate
EA200100992A1 (ru) Ингибиторы фермента impdh
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
EA200870127A1 (ru) Полициклические производные аминокислот и способы их применения
EA200500703A1 (ru) Новые трициклические соединения для лечения воспалительных и аллергических нарушений, способ их приготовления и содержащие их фармацевтические составы
EA200400491A1 (ru) Полиморфная форма римонабанта, способ её получения и содержащие её фармацевтические композиции
EA200700909A1 (ru) Азаиндолкарбоксамиды
NO20073678L (no) Nye fremgangsmater for fremstilling av benzofuran
EA200600605A1 (ru) Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств
MY158159A (en) Novel fused pyrrolocarbazoles
SG149042A1 (en) Novel fused pyrrolocarbazoles
EA200301120A1 (ru) Цитрат 5,8,14-триазатетрацикло (10.3.1.0.0)-гексадека-2 (11),3,5,7,9-пентаена
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
BR0318521A (pt) arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados
EA200000322A1 (ru) Способ синтеза производных хинолина
SG144921A1 (en) Method and intermediates for the preparation of derivatives of n-(1- benzhydrylazetidin-3-yl)-n-phenylmethylsulphonamide